
<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Alexander+Berchansky</id>
	<title>Proteopedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://proteopedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Alexander+Berchansky"/>
	<link rel="alternate" type="text/html" href="https://proteopedia.org/Special:Contributions/Alexander_Berchansky"/>
	<updated>2026-09-15T01:01:29Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304583</id>
		<title>Sandbox FIg 5b</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304583"/>
		<updated>2025-02-12T10:00:46Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;&#039; size=&#039;200&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;&lt;br /&gt;
This is a default text for your page &#039;&#039;&#039;Sandbox FIg 5b&#039;&#039;&#039;. Click above on &#039;&#039;&#039;edit this page&#039;&#039;&#039; to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;br /&gt;
You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;009 Fig 5b_png&amp;lt;/scene&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_default_jmol/2&#039;&amp;gt;009 Fig 5b_png_created_with_default_jmol&amp;lt;/scene&amp;gt;&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
an &amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_metal_tcache_lab_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_apo_tcache_lab_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between them. The stability of the 4D motif is attributed to adjacent positively charged residues (Lys325, Arg388, and Arg517), forming stabilizing salt bridges, leading to the newly named &amp;lt;scene name=&#039;10/1063617/009_figu_5b_png/3&#039;&amp;gt;4A/3B motif&amp;lt;/scene&amp;gt; (four acidic residues stabilized by three basic residues).&lt;br /&gt;
&lt;br /&gt;
The study also identified additional metal-binding sites (His264 and His471 sites) in &#039;&#039;Tc&#039;&#039;AChE through crystallographic analysis, but these appear to be weaker or crystallographic artifacts. Using metadynamics and molecular dynamics (MD) simulations with quantum potentials (QM/MM-MD), the binding strength of metal cations at the 4D site was compared to that of the 4D site in human fibrin-stabilizing factor (fXIIIa), which lacks stabilizing cationic residues. Results showed that while &#039;&#039;Tc&#039;&#039;AChE’s 4A/3B motif maintains structural integrity upon metal binding/unbinding, the &amp;lt;scene name=&#039;10/1063617/009_figu_8a_png/2&#039;&amp;gt;fXIIIa motif &amp;lt;/scene&amp;gt; is stable in presence of a metal ion but &amp;lt;scene name=&#039;10/1063617/009_figu_8b_png/2&#039;&amp;gt;explodes&amp;lt;/scene&amp;gt; without a metal ions due to electrostatic repulsion. This is seen clearly in an &lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8a_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8b_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between these two states.&lt;br /&gt;
== Relevance ==&lt;br /&gt;
&lt;br /&gt;
== Structural highlights ==&lt;br /&gt;
&lt;br /&gt;
This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304582</id>
		<title>Sandbox FIg 5b</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304582"/>
		<updated>2025-02-12T10:00:25Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;&#039; size=&#039;500&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;&lt;br /&gt;
This is a default text for your page &#039;&#039;&#039;Sandbox FIg 5b&#039;&#039;&#039;. Click above on &#039;&#039;&#039;edit this page&#039;&#039;&#039; to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;br /&gt;
You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;009 Fig 5b_png&amp;lt;/scene&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_default_jmol/2&#039;&amp;gt;009 Fig 5b_png_created_with_default_jmol&amp;lt;/scene&amp;gt;&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
an &amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_metal_tcache_lab_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_apo_tcache_lab_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between them. The stability of the 4D motif is attributed to adjacent positively charged residues (Lys325, Arg388, and Arg517), forming stabilizing salt bridges, leading to the newly named &amp;lt;scene name=&#039;10/1063617/009_figu_5b_png/3&#039;&amp;gt;4A/3B motif&amp;lt;/scene&amp;gt; (four acidic residues stabilized by three basic residues).&lt;br /&gt;
&lt;br /&gt;
The study also identified additional metal-binding sites (His264 and His471 sites) in &#039;&#039;Tc&#039;&#039;AChE through crystallographic analysis, but these appear to be weaker or crystallographic artifacts. Using metadynamics and molecular dynamics (MD) simulations with quantum potentials (QM/MM-MD), the binding strength of metal cations at the 4D site was compared to that of the 4D site in human fibrin-stabilizing factor (fXIIIa), which lacks stabilizing cationic residues. Results showed that while &#039;&#039;Tc&#039;&#039;AChE’s 4A/3B motif maintains structural integrity upon metal binding/unbinding, the &amp;lt;scene name=&#039;10/1063617/009_figu_8a_png/2&#039;&amp;gt;fXIIIa motif &amp;lt;/scene&amp;gt; is stable in presence of a metal ion but &amp;lt;scene name=&#039;10/1063617/009_figu_8b_png/2&#039;&amp;gt;explodes&amp;lt;/scene&amp;gt; without a metal ions due to electrostatic repulsion. This is seen clearly in an &lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8a_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8b_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between these two states.&lt;br /&gt;
== Relevance ==&lt;br /&gt;
&lt;br /&gt;
== Structural highlights ==&lt;br /&gt;
&lt;br /&gt;
This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304581</id>
		<title>Sandbox FIg 5b</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304581"/>
		<updated>2025-02-12T09:59:57Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;&#039; size=&#039;600&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;&lt;br /&gt;
This is a default text for your page &#039;&#039;&#039;Sandbox FIg 5b&#039;&#039;&#039;. Click above on &#039;&#039;&#039;edit this page&#039;&#039;&#039; to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;br /&gt;
You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;009 Fig 5b_png&amp;lt;/scene&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_default_jmol/2&#039;&amp;gt;009 Fig 5b_png_created_with_default_jmol&amp;lt;/scene&amp;gt;&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
an &amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_metal_tcache_lab_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_apo_tcache_lab_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between them. The stability of the 4D motif is attributed to adjacent positively charged residues (Lys325, Arg388, and Arg517), forming stabilizing salt bridges, leading to the newly named &amp;lt;scene name=&#039;10/1063617/009_figu_5b_png/3&#039;&amp;gt;4A/3B motif&amp;lt;/scene&amp;gt; (four acidic residues stabilized by three basic residues).&lt;br /&gt;
&lt;br /&gt;
The study also identified additional metal-binding sites (His264 and His471 sites) in &#039;&#039;Tc&#039;&#039;AChE through crystallographic analysis, but these appear to be weaker or crystallographic artifacts. Using metadynamics and molecular dynamics (MD) simulations with quantum potentials (QM/MM-MD), the binding strength of metal cations at the 4D site was compared to that of the 4D site in human fibrin-stabilizing factor (fXIIIa), which lacks stabilizing cationic residues. Results showed that while &#039;&#039;Tc&#039;&#039;AChE’s 4A/3B motif maintains structural integrity upon metal binding/unbinding, the &amp;lt;scene name=&#039;10/1063617/009_figu_8a_png/2&#039;&amp;gt;fXIIIa motif &amp;lt;/scene&amp;gt; is stable in presence of a metal ion but &amp;lt;scene name=&#039;10/1063617/009_figu_8b_png/2&#039;&amp;gt;explodes&amp;lt;/scene&amp;gt; without a metal ions due to electrostatic repulsion. This is seen clearly in an &lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8a_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8b_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between these two states.&lt;br /&gt;
== Relevance ==&lt;br /&gt;
&lt;br /&gt;
== Structural highlights ==&lt;br /&gt;
&lt;br /&gt;
This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304580</id>
		<title>Sandbox FIg 5b</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304580"/>
		<updated>2025-02-12T09:59:07Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;&#039; size=&#039;600 side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;&lt;br /&gt;
This is a default text for your page &#039;&#039;&#039;Sandbox FIg 5b&#039;&#039;&#039;. Click above on &#039;&#039;&#039;edit this page&#039;&#039;&#039; to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;br /&gt;
You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;009 Fig 5b_png&amp;lt;/scene&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_default_jmol/2&#039;&amp;gt;009 Fig 5b_png_created_with_default_jmol&amp;lt;/scene&amp;gt;&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
an &amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_metal_tcache_lab_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_apo_tcache_lab_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between them. The stability of the 4D motif is attributed to adjacent positively charged residues (Lys325, Arg388, and Arg517), forming stabilizing salt bridges, leading to the newly named &amp;lt;scene name=&#039;10/1063617/009_figu_5b_png/3&#039;&amp;gt;4A/3B motif&amp;lt;/scene&amp;gt; (four acidic residues stabilized by three basic residues).&lt;br /&gt;
&lt;br /&gt;
The study also identified additional metal-binding sites (His264 and His471 sites) in &#039;&#039;Tc&#039;&#039;AChE through crystallographic analysis, but these appear to be weaker or crystallographic artifacts. Using metadynamics and molecular dynamics (MD) simulations with quantum potentials (QM/MM-MD), the binding strength of metal cations at the 4D site was compared to that of the 4D site in human fibrin-stabilizing factor (fXIIIa), which lacks stabilizing cationic residues. Results showed that while &#039;&#039;Tc&#039;&#039;AChE’s 4A/3B motif maintains structural integrity upon metal binding/unbinding, the &amp;lt;scene name=&#039;10/1063617/009_figu_8a_png/2&#039;&amp;gt;fXIIIa motif &amp;lt;/scene&amp;gt; is stable in presence of a metal ion but &amp;lt;scene name=&#039;10/1063617/009_figu_8b_png/2&#039;&amp;gt;explodes&amp;lt;/scene&amp;gt; without a metal ions due to electrostatic repulsion. This is seen clearly in an &lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8a_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8b_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between these two states.&lt;br /&gt;
== Relevance ==&lt;br /&gt;
&lt;br /&gt;
== Structural highlights ==&lt;br /&gt;
&lt;br /&gt;
This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304579</id>
		<title>Sandbox FIg 5b</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304579"/>
		<updated>2025-02-12T09:58:44Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;&#039; size=&#039;300&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;&lt;br /&gt;
This is a default text for your page &#039;&#039;&#039;Sandbox FIg 5b&#039;&#039;&#039;. Click above on &#039;&#039;&#039;edit this page&#039;&#039;&#039; to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;br /&gt;
You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;009 Fig 5b_png&amp;lt;/scene&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_default_jmol/2&#039;&amp;gt;009 Fig 5b_png_created_with_default_jmol&amp;lt;/scene&amp;gt;&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
an &amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_metal_tcache_lab_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_apo_tcache_lab_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between them. The stability of the 4D motif is attributed to adjacent positively charged residues (Lys325, Arg388, and Arg517), forming stabilizing salt bridges, leading to the newly named &amp;lt;scene name=&#039;10/1063617/009_figu_5b_png/3&#039;&amp;gt;4A/3B motif&amp;lt;/scene&amp;gt; (four acidic residues stabilized by three basic residues).&lt;br /&gt;
&lt;br /&gt;
The study also identified additional metal-binding sites (His264 and His471 sites) in &#039;&#039;Tc&#039;&#039;AChE through crystallographic analysis, but these appear to be weaker or crystallographic artifacts. Using metadynamics and molecular dynamics (MD) simulations with quantum potentials (QM/MM-MD), the binding strength of metal cations at the 4D site was compared to that of the 4D site in human fibrin-stabilizing factor (fXIIIa), which lacks stabilizing cationic residues. Results showed that while &#039;&#039;Tc&#039;&#039;AChE’s 4A/3B motif maintains structural integrity upon metal binding/unbinding, the &amp;lt;scene name=&#039;10/1063617/009_figu_8a_png/2&#039;&amp;gt;fXIIIa motif &amp;lt;/scene&amp;gt; is stable in presence of a metal ion but &amp;lt;scene name=&#039;10/1063617/009_figu_8b_png/2&#039;&amp;gt;explodes&amp;lt;/scene&amp;gt; without a metal ions due to electrostatic repulsion. This is seen clearly in an &lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8a_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8b_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between these two states.&lt;br /&gt;
== Relevance ==&lt;br /&gt;
&lt;br /&gt;
== Structural highlights ==&lt;br /&gt;
&lt;br /&gt;
This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304578</id>
		<title>Sandbox FIg 5b</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304578"/>
		<updated>2025-02-12T09:58:17Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;&lt;br /&gt;
This is a default text for your page &#039;&#039;&#039;Sandbox FIg 5b&#039;&#039;&#039;. Click above on &#039;&#039;&#039;edit this page&#039;&#039;&#039; to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;br /&gt;
You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;009 Fig 5b_png&amp;lt;/scene&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_default_jmol/2&#039;&amp;gt;009 Fig 5b_png_created_with_default_jmol&amp;lt;/scene&amp;gt;&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
an &amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_metal_tcache_lab_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_apo_tcache_lab_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between them. The stability of the 4D motif is attributed to adjacent positively charged residues (Lys325, Arg388, and Arg517), forming stabilizing salt bridges, leading to the newly named &amp;lt;scene name=&#039;10/1063617/009_figu_5b_png/3&#039;&amp;gt;4A/3B motif&amp;lt;/scene&amp;gt; (four acidic residues stabilized by three basic residues).&lt;br /&gt;
&lt;br /&gt;
The study also identified additional metal-binding sites (His264 and His471 sites) in &#039;&#039;Tc&#039;&#039;AChE through crystallographic analysis, but these appear to be weaker or crystallographic artifacts. Using metadynamics and molecular dynamics (MD) simulations with quantum potentials (QM/MM-MD), the binding strength of metal cations at the 4D site was compared to that of the 4D site in human fibrin-stabilizing factor (fXIIIa), which lacks stabilizing cationic residues. Results showed that while &#039;&#039;Tc&#039;&#039;AChE’s 4A/3B motif maintains structural integrity upon metal binding/unbinding, the &amp;lt;scene name=&#039;10/1063617/009_figu_8a_png/2&#039;&amp;gt;fXIIIa motif &amp;lt;/scene&amp;gt; is stable in presence of a metal ion but &amp;lt;scene name=&#039;10/1063617/009_figu_8b_png/2&#039;&amp;gt;explodes&amp;lt;/scene&amp;gt; without a metal ions due to electrostatic repulsion. This is seen clearly in an &lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8a_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8b_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between these two states.&lt;br /&gt;
== Relevance ==&lt;br /&gt;
&lt;br /&gt;
== Structural highlights ==&lt;br /&gt;
&lt;br /&gt;
This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304577</id>
		<title>Sandbox FIg 5b</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Sandbox_FIg_5b&amp;diff=4304577"/>
		<updated>2025-02-12T09:57:19Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Your Heading Here (maybe something like &#039;Structure&#039;)==&lt;br /&gt;
&amp;lt;StructureSection load=&#039;1stp&#039; size=&#039;450&#039; side=&#039;right&#039; caption=&#039;Caption for this structure&#039; scene=&#039;&#039;&amp;gt;&lt;br /&gt;
This is a default text for your page &#039;&#039;&#039;Sandbox FIg 5b&#039;&#039;&#039;. Click above on &#039;&#039;&#039;edit this page&#039;&#039;&#039; to modify. Be careful with the &amp;amp;lt; and &amp;amp;gt; signs.&lt;br /&gt;
You may include any references to papers as in: the use of JSmol in Proteopedia &amp;lt;ref&amp;gt;DOI 10.1002/ijch.201300024&amp;lt;/ref&amp;gt; or to the article describing Jmol &amp;lt;ref&amp;gt;PMID:21638687&amp;lt;/ref&amp;gt; to the rescue.&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_png/2&#039;&amp;gt;009 Fig 5b_png&amp;lt;/scene&amp;gt;&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;scene name=&#039;10/1072773/009_fig_5b_default_jmol/2&#039;&amp;gt;009 Fig 5b_png_created_with_default_jmol&amp;lt;/scene&amp;gt;&lt;br /&gt;
== Disease ==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
an &amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_metal_tcache_lab_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_fig_apo_tcache_lab_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between them. The stability of the 4D motif is attributed to adjacent positively charged residues (Lys325, Arg388, and Arg517), forming stabilizing salt bridges, leading to the newly named &amp;lt;scene name=&#039;10/1063617/009_figu_5b_png/3&#039;&amp;gt;4A/3B motif&amp;lt;/scene&amp;gt; (four acidic residues stabilized by three basic residues).&lt;br /&gt;
&lt;br /&gt;
The study also identified additional metal-binding sites (His264 and His471 sites) in &#039;&#039;Tc&#039;&#039;AChE through crystallographic analysis, but these appear to be weaker or crystallographic artifacts. Using metadynamics and molecular dynamics (MD) simulations with quantum potentials (QM/MM-MD), the binding strength of metal cations at the 4D site was compared to that of the 4D site in human fibrin-stabilizing factor (fXIIIa), which lacks stabilizing cationic residues. Results showed that while &#039;&#039;Tc&#039;&#039;AChE’s 4A/3B motif maintains structural integrity upon metal binding/unbinding, the &amp;lt;scene name=&#039;10/1063617/009_figu_8a_png/2&#039;&amp;gt;fXIIIa motif &amp;lt;/scene&amp;gt; is stable in presence of a metal ion but &amp;lt;scene name=&#039;10/1063617/009_figu_8b_png/2&#039;&amp;gt;explodes&amp;lt;/scene&amp;gt; without a metal ions due to electrostatic repulsion. This is seen clearly in an &lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animation&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;&lt;br /&gt;
    var a = [1,2,3,4,5];&lt;br /&gt;
    for(var i IN a) {&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8a_png/2.spt; delay 0.5&lt;br /&gt;
      script /wiki/scripts/10/1063617/009_figu_8b_png/2.spt; delay 0.5;&lt;br /&gt;
    }&lt;br /&gt;
  &amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt; between these two states.&lt;br /&gt;
== Relevance ==&lt;br /&gt;
&lt;br /&gt;
== Structural highlights ==&lt;br /&gt;
&lt;br /&gt;
This is a sample scene created with SAT to &amp;lt;scene name=&amp;quot;/12/3456/Sample/1&amp;quot;&amp;gt;color&amp;lt;/scene&amp;gt; by Group, and another to make &amp;lt;scene name=&amp;quot;/12/3456/Sample/2&amp;quot;&amp;gt;a transparent representation&amp;lt;/scene&amp;gt; of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4187209</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4187209"/>
		<updated>2024-06-30T07:35:15Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/5&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caixdock/1&#039;&amp;gt;VD10-35 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caix/1&#039;&amp;gt;VD12-05 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxiii/2&#039;&amp;gt;VD12-05 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5lln]]). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4187172</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4187172"/>
		<updated>2024-06-27T09:27:47Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caien/2&#039;&amp;gt;VD11-4-2 CA I, energy&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/5&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/6&#039;&amp;gt;VD11-4-2 CA II, energy&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caixdock/1&#039;&amp;gt;VD10-35 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caix/1&#039;&amp;gt;VD12-05 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxiii/2&#039;&amp;gt;VD12-05 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5lln]]). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4187171</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4187171"/>
		<updated>2024-06-27T09:09:45Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caien/2&#039;&amp;gt;VD11-4-2 CA I, energy&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/5&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caixdock/1&#039;&amp;gt;VD10-35 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caix/1&#039;&amp;gt;VD12-05 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxiii/2&#039;&amp;gt;VD12-05 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5lln]]). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186130</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186130"/>
		<updated>2024-06-25T17:22:57Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caien/2&#039;&amp;gt;VD11-4-2 CA I, energy&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caixdock/1&#039;&amp;gt;VD10-35 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caix/1&#039;&amp;gt;VD12-05 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxiii/2&#039;&amp;gt;VD12-05 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5lln]]). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186129</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186129"/>
		<updated>2024-06-25T17:19:19Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caien/1&#039;&amp;gt;VD11-4-2 CA I, energy&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caixdock/1&#039;&amp;gt;VD10-35 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caix/1&#039;&amp;gt;VD12-05 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxiii/2&#039;&amp;gt;VD12-05 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5lln]]). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186128</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186128"/>
		<updated>2024-06-25T15:47:49Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caixdock/1&#039;&amp;gt;VD10-35 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caix/1&#039;&amp;gt;VD12-05 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxiii/2&#039;&amp;gt;VD12-05 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5lln]]). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:3iaiA.pdb&amp;diff=4186127</id>
		<title>File:3iaiA.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:3iaiA.pdb&amp;diff=4186127"/>
		<updated>2024-06-25T15:38:57Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:3iaidock.pdb&amp;diff=4186126</id>
		<title>File:3iaidock.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:3iaidock.pdb&amp;diff=4186126"/>
		<updated>2024-06-25T15:35:34Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186125</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186125"/>
		<updated>2024-06-25T15:28:21Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caixdock/1&#039;&amp;gt;VD10-35 CA IX docked&amp;lt;/scene&amp;gt;.&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxiii/2&#039;&amp;gt;VD12-05 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5lln]]). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:CA9-3iai.pdb&amp;diff=4186124</id>
		<title>File:CA9-3iai.pdb</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:CA9-3iai.pdb&amp;diff=4186124"/>
		<updated>2024-06-25T15:14:35Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186123</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186123"/>
		<updated>2024-06-25T14:53:41Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxiii/2&#039;&amp;gt;VD12-05 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5lln]]). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186122</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186122"/>
		<updated>2024-06-25T14:39:53Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caxii/1&#039;&amp;gt;VD12-05 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msa]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186121</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186121"/>
		<updated>2024-06-25T13:54:00Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05caii/1&#039;&amp;gt;VD12-05 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4ww6]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186120</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186120"/>
		<updated>2024-06-25T13:38:57Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD12-05:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd12-05cai/1&#039;&amp;gt;VD12-05 CA I&amp;lt;/scene&amp;gt; (PDB ID [[4wr7]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186094</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186094"/>
		<updated>2024-06-24T13:03:34Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxiii/1&#039;&amp;gt;VD10-35 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[4hu1]]).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186093</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186093"/>
		<updated>2024-06-24T12:51:10Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caxii/1&#039;&amp;gt;VD10-35 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[5msb]]).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186092</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186092"/>
		<updated>2024-06-24T12:02:07Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd10-35caii/3&#039;&amp;gt;VD10-35 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pzh]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186091</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186091"/>
		<updated>2024-06-24T11:49:12Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound VD10-35:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186090</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186090"/>
		<updated>2024-06-24T11:41:33Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxiii/3&#039;&amp;gt;VD11-4-2 CA XIII&amp;lt;/scene&amp;gt; (PDB ID [[5e2n]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186087</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186087"/>
		<updated>2024-06-24T10:29:33Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caxii/3&#039;&amp;gt;VD11-4-2 CA XII&amp;lt;/scene&amp;gt; (PDB ID [[4q0l]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186082</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186082"/>
		<updated>2024-06-24T10:12:38Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Compound Vd11-4-2:&#039;&#039;&#039;&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186081</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186081"/>
		<updated>2024-06-24T10:12:23Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
Compound Vd11-4-2:&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CA I&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CA II&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caix/2&#039;&amp;gt;VD11-4-2 CA IX&amp;lt;/scene&amp;gt; (PDB ID [[6fe1]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186052</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186052"/>
		<updated>2024-06-23T15:16:27Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
Compound Vd11-4-2:&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CAI&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/2&#039;&amp;gt;VD11-4-2 CAII&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186051</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186051"/>
		<updated>2024-06-23T15:13:40Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
Compound Vd11-4-2:&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CAI&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2caii/1&#039;&amp;gt;VD11-4-2 CAII&amp;lt;/scene&amp;gt; (PDB ID [[4pyy]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005461&amp;diff=4186050</id>
		<title>Journal:Acta Cryst D:S2059798324005461</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005461&amp;diff=4186050"/>
		<updated>2024-06-23T14:40:41Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1050894/Cv/1&#039; caption=&#039;&#039;&amp;gt;__NOTOC__&lt;br /&gt;
===Toward a dependable data set of structures for L-asparaginase===&lt;br /&gt;
&amp;lt;big&amp;gt;Alexander Wlodawer, Zbigniew Dauter, Jacek Lubkowski, Joanna I. Loch, Dariusz Brzezinski, Miroslaw Gilski, Mariusz Jaskolski&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2059798324005461&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
==Molecular Tour==&lt;br /&gt;
L-Asparaginase (ASNase) catalyzes the hydrolysis of L-Asn to L-Asp, according to the reaction:&lt;br /&gt;
&amp;lt;b&amp;gt;ASNase + L-Asn + H2O → ASNase + L-Asp + NH3&amp;lt;/b&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Most ASNases have at least residual glutaminolytic activity, which in some cases exceeds the asparaginolytic activity and is often associated with the name glutaminase-asparaginase. Whereas first identified in a mammalian source, these enzymes were also found in bacteria, archaea, and eukarya. Members of the ASNase family primarily catalyze the hydrolysis of unmodified L-Asn. There are several groups of ASNases, defined by such factors as the source organism, amino acid sequence, 3D structure, substrate-specificity, biophysical properties, etc. So far, three completely different structural Classes of ASNases have been identified, originally named according to the source organism of their isolation, namely Class 1 (bacterial-type), Class 2 (plant-type), and Class 3 (Rhizobium etli-type). This new classification is intersected with an older convention, which divided the known enzymes with L-asparaginase activity into five types, since in both, Class 1 and Class 3, there are two types distinguished according to their compartmentalization and expression profile. The prototypes of types I and II (in Class 1), and III (in Class 2), are the E. coli enzymes EcAI (cytosolic), EcAII (periplasmic), and EcAIII (also cytosolic), respectively. The prototypes of types IV and V (Class 3) are the R. etli enzymes ReAIV (constitutive) and ReAV (inducible).&lt;br /&gt;
&lt;br /&gt;
Beyond pure academic curiosity, ASNases are also studied because of their potential application as first-line drugs for the treatment of acute lymphoblastic leukemia (ALL). Since the late 1970s, Class 1 type II L-asparaginases of bacterial origin have been used in the clinical treatment of ALL, and there are recent reports that ASNases could be effective against solid tumors as well. However, in view of the frequent severe side effects accompanying current administration protocols, it is not surprising that significant research effort has been directed into engineering the other types of ASNases into useful drugs. Thus, careful analysis of all known structures of ASNases, with the view of indicating enzymes with potential for becoming novel therapeutics, is still very important. &lt;br /&gt;
==Dependable Structures==&lt;br /&gt;
&amp;lt;jmol&amp;gt;&amp;lt;jmolMenu&amp;gt;&lt;br /&gt;
  &amp;lt;item&amp;gt;&amp;lt;text&amp;gt;Select dependable structure&amp;lt;/text&amp;gt;&lt;br /&gt;
  &amp;lt;script&amp;gt;zap;&amp;lt;/script&amp;gt;&lt;br /&gt;
&amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;1agx&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/1agx_revised.cif&amp;quot; &amp;quot;*1agx&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;1nns&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/1nns_revised.cif&amp;quot; &amp;quot;*1nns&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;1o7j&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/1o7j_revised.cif&amp;quot; &amp;quot;*1o7j&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;1wls&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/1wls_revised.cif&amp;quot; &amp;quot;*1wls&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;1zcf&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/1zcf_revised.cif&amp;quot; &amp;quot;*1zcf&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;2gvn&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/2gvn_revised.cif&amp;quot; &amp;quot;*2gvn&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;2jk0&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/2jk0_revised.cif&amp;quot; &amp;quot;*2jk0&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;2wlt&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/2wlt_revised.cif&amp;quot; &amp;quot;*2wlt&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;3pga&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/3pga_revised.cif&amp;quot; &amp;quot;*3pga&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;4o47&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/4o47_revised.cif&amp;quot; &amp;quot;*4o47&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;4q0m&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/4q0m_revised.cif&amp;quot; &amp;quot;*4q0m&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;5b74&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/5b74_revised.cif&amp;quot; &amp;quot;*5b74&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;5k3o&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/5k3o_revised.cif&amp;quot; &amp;quot;*5k3o&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;5k45&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/5k45_revised.cif&amp;quot; &amp;quot;*5k45&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;5k4g&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/5k4g_revised.cif&amp;quot; &amp;quot;*5k4g&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;5mq5&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/5mq5_revised.cif&amp;quot; &amp;quot;*5mq5&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;5ot0&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/5ot0_revised.cif&amp;quot; &amp;quot;*5ot0&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;6rud&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/6rud_revised.cif&amp;quot; &amp;quot;*6rud&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;6ruf&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/6ruf_revised.cif&amp;quot; &amp;quot;*6ruf&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;6syh&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/6syh_revised.cif&amp;quot; &amp;quot;*6syh&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;6uog&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/6uog_revised.cif&amp;quot; &amp;quot;*6uog&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;6v5f&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/6v5f_revised.cif&amp;quot; &amp;quot;*6v5f&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;6wz6&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/6wz6_revised.cif&amp;quot; &amp;quot;*6wz6&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;7a0u&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/7a0u_revised.cif&amp;quot; &amp;quot;*7a0u&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;7p9c&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/7p9c_revised.cif&amp;quot; &amp;quot;*7p9c&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;7r57&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/7r57_revised.cif&amp;quot; &amp;quot;*7r57&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;7r5q&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/7r5q_revised.cif&amp;quot; &amp;quot;*7r5q&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;7u6m&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/7u6m_revised.cif&amp;quot; &amp;quot;*7u6m&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;8ecd&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/8ecd_revised.cif&amp;quot; &amp;quot;*8ecd&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
  &amp;lt;item&amp;gt;&lt;br /&gt;
    &amp;lt;text&amp;gt;8h48&amp;lt;/text&amp;gt;&lt;br /&gt;
    &amp;lt;script&amp;gt;zap; &lt;br /&gt;
      load files &amp;quot;/cgi-bin/pprstr?bc356b44effd36197439439e31c1852b/8h48_revised.cif&amp;quot; &amp;quot;*8h48&amp;quot;; &lt;br /&gt;
      script /cgi-bin/superimpose;&lt;br /&gt;
    &amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;/item&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;/jmolMenu&amp;gt;&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;script&amp;gt;!exit; model 1&amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;dependable structure&amp;lt;/text&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;script&amp;gt;!exit; model 2&amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;deposited structure&amp;lt;/text&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmol&amp;gt;&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;script&amp;gt;!exit; model 0&amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;both structures&amp;lt;/text&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;script&amp;gt;animation mode loop; animation on&amp;lt;/script&amp;gt;&lt;br /&gt;
  &amp;lt;text&amp;gt;animate&amp;lt;/text&amp;gt;&lt;br /&gt;
&amp;lt;/jmolButton&amp;gt;&lt;br /&gt;
&amp;lt;/jmol&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186049</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186049"/>
		<updated>2024-06-23T13:21:01Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
Compound Vd11-4-2:&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CAI&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186003</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186003"/>
		<updated>2024-06-20T16:15:14Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
Compound Vd11-4-2:&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CAI&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/4&#039;&amp;gt;Test&amp;lt;/scene&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:5e2mt.pse&amp;diff=4186002</id>
		<title>File:5e2mt.pse</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:5e2mt.pse&amp;diff=4186002"/>
		<updated>2024-06-20T15:49:44Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=File:5e2mt.zip&amp;diff=4186001</id>
		<title>File:5e2mt.zip</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=File:5e2mt.zip&amp;diff=4186001"/>
		<updated>2024-06-20T15:46:48Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186000</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4186000"/>
		<updated>2024-06-20T15:18:08Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
Compound Vd11-4-2:&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CAI&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182486</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182486"/>
		<updated>2024-06-18T05:52:52Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
Compound Vd11-4-2:&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CAI&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/3&#039;&amp;gt;Test&amp;lt;/scene&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182485</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182485"/>
		<updated>2024-06-18T05:44:23Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
Compound Vd11-4-2:&lt;br /&gt;
*&amp;lt;scene name=&#039;10/1051456/Vd11-4-2cai/2&#039;&amp;gt;VD11-4-2 CAI&amp;lt;/scene&amp;gt; (PDB ID [[5e2m]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182484</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182484"/>
		<updated>2024-06-18T05:21:32Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1051456/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182483</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182483"/>
		<updated>2024-06-18T05:12:30Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;underdevelopment&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database ([https://plbd.org/db/ plbd.org]) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182482</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182482"/>
		<updated>2024-06-18T05:09:56Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;underdevelopment&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Rational design of novel pharmaceutical molecules requires deep understanding of how small molecules recognize and bind to the disease target protein molecule. Unfortunately, the mechanism of recognition is still quite poorly understood. Experimentally, the binding reaction can be described structurally and energetically. The X-ray crystallographic structure of the drug candidate molecule bound to the protein molecule provides detailed information on the structural arrangement and the interface between the compound and the protein. However, the structural information does not yield a clue on the strength and affinity, thus the energy of the interaction. Full energetic description should include the measurement of the thermodynamic binding parameters, including the Gibbs energy, enthalpy, entropy, heat capacity, compressibility, and several others and the kinetic parameters, especially the dissociation rate constant or residence time. When the reaction is fully characterized both structurally and energetically, we can begin studying the principles of structure – thermodynamics correlations.&lt;br /&gt;
However, both the structural and energetic characterization may succumb to numerous pitfalls. The structure of the protein – ligand complex may be determined by numerous structural methods, such as X-ray crystallography, NMR, and Cryo-EM. The conditions of these experiments may vary a lot, the temperature may be 100K, much lower than the physiological temperature. Dynamic information may be more accessible in NMR than in other methods. Limited resolution may also be insufficient to determine exact positions of all atoms including hydrogens. There are always limitations of what the structural picture can provide. On the other hand, energetic description is also highly complex. There are numerous techniques to characterize the affinity and other thermodynamic parameters of binding. Each technique has limitations as described in this manuscript. However, here we especially emphasize the intrinsic energetics of binding. Numerous protein – ligand binding reactions are linked to protonation reactions that contribute significant energies and without the dissection of such energies it is impossible to draw proper structure – thermodynamics correlations.&lt;br /&gt;
In this manuscript we illustrate how detailed structural and thermodynamic characterization, especially taking into account the intrinsic parameters, helped to design high-affinity and high-specificity chemical compounds that would bind carbonic anhydrase IX (CAIX), a protein that is highly overexpressed in most solid hypoxic tumors. The protein participates in the acidification of the tumor microenvironment, helps promote invasion and metastasis processes in cancer. Thus, a possible anticancer strategy could involve inhibition of the protein by inhibitors that would not bind to any other proteins and thus not cause possible toxic side effects. We synthesized over 1000 molecules and demonstrated chemical structure features of a compound to exhibit high affinity for CAIX and low affinity for remaining 11 catalytically active vital human carbonic anhydrase isozymes. The compounds were arranged into a database (plbd.org) to help researchers apply AI approaches and study the structure – thermodynamics correlations for rational drug design.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182481</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182481"/>
		<updated>2024-06-17T15:00:36Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;underdevelopment&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Vaida Paketuryte-Latve, Alexey Smirnov, Elena Manakova, Lina Baranauskiene, Vytautas Petrauskas, Asta Zubriene, Jurgita Matuliene, Virginija Dudutiene, Edita Capkauskaite, Audrius Zaksauskas, Janis Leitans, Saulius Grazulis, Kaspars&lt;br /&gt;
Tars and Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182480</id>
		<title>Journal:Acta Cryst D:S2059798324005229</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182480"/>
		<updated>2024-06-17T14:46:58Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1050322/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===Factors affecting macromolecule orientations in thin films formed in cryo-EM===&lt;br /&gt;
&amp;lt;big&amp;gt;Swati Yadav and Vinothkumar Kutti Ragunath&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2059798324005229&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Single particle cryo-EM has become a routine and indispensable technique in structural biology, where macromolecules are imaged with electrons as single particles and subsequently averaged to obtain a high-resolution 3D reconstruction. Single particle cryo-EM reconstruction utilizes the projection slice theorem to build a 3D map of a 3D object using 2D projections, generated when electrons transmitted through a thin specimen are recorded by a detector. The resolution and quality of the final map depend on many factors including heterogeneity in the specimen, adequate sampling of views and signal-to-noise of the images. &lt;br /&gt;
A key step in this process is to obtain a thin film of macromolecules (purified or as a mixture) in ice and the most routinely used method for obtaining such thin films was developed by Dubochet and his colleagues (Dubochet &#039;&#039;et al.,&#039;&#039; 1988&amp;lt;ref name=&amp;quot;Dubochet1&amp;quot;&amp;gt;PMID:3043536&amp;lt;/ref&amp;gt;). Obtaining the optimal conditions for freezing of a given macromolecule requires testing several parameters. At the moment, it is one of the rate-limiting steps in obtaining high-resolution maps by cryo-EM. During the freezing process, the macromolecules can encounter and interact with the air-water interface, sometimes resulting in a tendency to adapt one or more preferential orientations along with denaturation and dissociation in the case of multi-subunit complexes (D’Imprima &#039;&#039;et al.,&#039;&#039; 2019&amp;lt;ref name=&amp;quot;D’Imprima&amp;quot;&amp;gt;PMID:30932812&amp;lt;/ref&amp;gt;; Noble &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Noble&amp;quot;&amp;gt;PMID: 30250056&amp;lt;/ref&amp;gt;; Glaeser and Han, 2017&amp;lt;ref name=&amp;quot;Glaeser&amp;quot;&amp;gt;PMID: 28781996&amp;lt;/ref&amp;gt;). The 3D maps reconstructed from preferentially oriented macromolecules exhibit stretching of densities in one direction (also called anisotropy, where with enough particles the resolution will be high but the maps are not easily interpretable). One such example is the spike protein shown in Figure 1A, which illustrates the effects of orientation bias on the final reconstruction.&lt;br /&gt;
[[Image:Figure1RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 1:&#039;&#039;&#039; The models used as reference are PDBs [[8h3d]] and [[6cvm]] for the spike protein and b-galactosidase respectively. A) Spike protein, SARS-COV-2. &amp;lt;scene name=&#039;10/1050322/Spike_no_additive/1&#039;&amp;gt;Spike, no additive&amp;lt;/scene&amp;gt; ([[8h3d]]). &amp;lt;scene name=&#039;10/1050322/Spike_with_ctab/1&#039;&amp;gt;Spike with CTAB&amp;lt;/scene&amp;gt; ([[8wzi]]). B) β-galactosidase.&lt;br /&gt;
&lt;br /&gt;
There are multiple ways to address orientation bias including the use of support layers like carbon or graphene, tilting of the stage and more commonly, the use of surfactants or detergents as small molecule additives during grid preparation (Liu and Wang, 2023&amp;lt;ref name=&amp;quot;Liu&amp;quot;&amp;gt;PMID: 36563741&amp;lt;/ref&amp;gt;). There are a number of macromolecules where surfactants have been used to overcome the preferred orientation problem. In this work, we asked if an informed decision regarding the grid freezing conditions can be made based on the properties of the macromolecule. &lt;br /&gt;
We studied macromolecules of different sizes and symmetries (125-440 kDa, C1 to D3) and tested a few commonly used surfactants to overcome the orientation bias and observed that many of these surfactants are beneficial. One such example is cationic surfactant CTAB, which causes changes in the orientation distribution of SARS-CoV-2 spike protein as shown in Figure1A. Further, we tested the effect of poly-histidine tag on orientation distribution of macromolecules. Figure 1B shows the impact of the N-terminal poly-his tag on orientation in the case of the E. coli β-galactosidase enzyme. We assessed the improvement in orientation distribution with different measures including the orientation distribution plot after 3D refinement (Scheres 2012&amp;lt;ref name=&amp;quot;Scheres&amp;quot;&amp;gt;PMID: 23000701&amp;lt;/ref&amp;gt;), Efficiency of orientation distribution (Naydenova &amp;amp; Russo, 2017&amp;lt;ref name=&amp;quot;Naydenova&amp;quot;&amp;gt;PMID: 28931821&amp;lt;/ref&amp;gt;), 3D-FSC (Tan &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Tan&amp;quot;&amp;gt;PMID: 28671674&amp;lt;/ref&amp;gt;) and the map vs model FSC curve. We also tested the effect of grid hole size and temperature during grid preparation on orientation bias demonstrated using human erythrocyte catalase as an example (Figure 2). &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure2RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 2:&#039;&#039;&#039; Human erythrocyte catalase. &amp;lt;scene name=&#039;10/1050322/Catalase/1&#039;&amp;gt;Catalase at 20 °C&amp;lt;/scene&amp;gt; (PDB ID [[8wzj]]).&lt;br /&gt;
&lt;br /&gt;
In summary, physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem (Figure 3). These findings lay a platform in achieving optimal freezing conditions for any given macromolecule in the future. &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure3RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 3&#039;&#039;&#039; Physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Crppentamer/3&#039;&amp;gt;CRP Pentamer with CTAB&amp;lt;/scene&amp;gt; (PDB ID [[8wv4]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Crpdecamer/1&#039;&amp;gt;CRP decamer with CTAB&amp;lt;/scene&amp;gt; (PDB ID [[8wv5]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Paaz/1&#039;&amp;gt;PaaZ with CTAB at 4 °C&amp;lt;/scene&amp;gt; (PDB ID [[8wv6]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182479</id>
		<title>Journal:Acta Cryst D:S2059798324005229</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182479"/>
		<updated>2024-06-17T14:34:48Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1050322/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===Factors affecting macromolecule orientations in thin films formed in cryo-EM===&lt;br /&gt;
&amp;lt;big&amp;gt;Swati Yadav and Vinothkumar Kutti Ragunath&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2059798324005229&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Single particle cryo-EM has become a routine and indispensable technique in structural biology, where macromolecules are imaged with electrons as single particles and subsequently averaged to obtain a high-resolution 3D reconstruction. Single particle cryo-EM reconstruction utilizes the projection slice theorem to build a 3D map of a 3D object using 2D projections, generated when electrons transmitted through a thin specimen are recorded by a detector. The resolution and quality of the final map depend on many factors including heterogeneity in the specimen, adequate sampling of views and signal-to-noise of the images. &lt;br /&gt;
A key step in this process is to obtain a thin film of macromolecules (purified or as a mixture) in ice and the most routinely used method for obtaining such thin films was developed by Dubochet and his colleagues (Dubochet &#039;&#039;et al.,&#039;&#039; 1988&amp;lt;ref name=&amp;quot;Dubochet1&amp;quot;&amp;gt;PMID:3043536&amp;lt;/ref&amp;gt;). Obtaining the optimal conditions for freezing of a given macromolecule requires testing several parameters. At the moment, it is one of the rate-limiting steps in obtaining high-resolution maps by cryo-EM. During the freezing process, the macromolecules can encounter and interact with the air-water interface, sometimes resulting in a tendency to adapt one or more preferential orientations along with denaturation and dissociation in the case of multi-subunit complexes (D’Imprima &#039;&#039;et al.,&#039;&#039; 2019&amp;lt;ref name=&amp;quot;D’Imprima&amp;quot;&amp;gt;PMID:30932812&amp;lt;/ref&amp;gt;; Noble &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Noble&amp;quot;&amp;gt;PMID: 30250056&amp;lt;/ref&amp;gt;; Glaeser and Han, 2017&amp;lt;ref name=&amp;quot;Glaeser&amp;quot;&amp;gt;PMID: 28781996&amp;lt;/ref&amp;gt;). The 3D maps reconstructed from preferentially oriented macromolecules exhibit stretching of densities in one direction (also called anisotropy, where with enough particles the resolution will be high but the maps are not easily interpretable). One such example is the spike protein shown in Figure 1A, which illustrates the effects of orientation bias on the final reconstruction.&lt;br /&gt;
[[Image:Figure1RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 1:&#039;&#039;&#039; The models used as reference are PDBs [[8h3d]] and [[6cvm]] for the spike protein and b-galactosidase respectively. A) Spike protein, SARS-COV-2. &amp;lt;scene name=&#039;10/1050322/Spike_no_additive/1&#039;&amp;gt;Spike, no additive&amp;lt;/scene&amp;gt; ([[8h3d]]). &amp;lt;scene name=&#039;10/1050322/Spike_with_ctab/1&#039;&amp;gt;Spike with CTAB&amp;lt;/scene&amp;gt; ([[8wzi]]). B) β-galactosidase.&lt;br /&gt;
&lt;br /&gt;
There are multiple ways to address orientation bias including the use of support layers like carbon or graphene, tilting of the stage and more commonly, the use of surfactants or detergents as small molecule additives during grid preparation (Liu and Wang, 2023&amp;lt;ref name=&amp;quot;Liu&amp;quot;&amp;gt;PMID: 36563741&amp;lt;/ref&amp;gt;). There are a number of macromolecules where surfactants have been used to overcome the preferred orientation problem. In this work, we asked if an informed decision regarding the grid freezing conditions can be made based on the properties of the macromolecule. &lt;br /&gt;
We studied macromolecules of different sizes and symmetries (125-440 kDa, C1 to D3) and tested a few commonly used surfactants to overcome the orientation bias and observed that many of these surfactants are beneficial. One such example is cationic surfactant CTAB, which causes changes in the orientation distribution of SARS-CoV-2 spike protein as shown in Figure1A. Further, we tested the effect of poly-histidine tag on orientation distribution of macromolecules. Figure 1B shows the impact of the N-terminal poly-his tag on orientation in the case of the E. coli β-galactosidase enzyme. We assessed the improvement in orientation distribution with different measures including the orientation distribution plot after 3D refinement (Scheres 2012&amp;lt;ref name=&amp;quot;Scheres&amp;quot;&amp;gt;PMID: 23000701&amp;lt;/ref&amp;gt;), Efficiency of orientation distribution (Naydenova &amp;amp; Russo, 2017&amp;lt;ref name=&amp;quot;Naydenova&amp;quot;&amp;gt;PMID: 28931821&amp;lt;/ref&amp;gt;), 3D-FSC (Tan &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Tan&amp;quot;&amp;gt;PMID: 28671674&amp;lt;/ref&amp;gt;) and the map vs model FSC curve. We also tested the effect of grid hole size and temperature during grid preparation on orientation bias demonstrated using human erythrocyte catalase as an example (Figure 2). &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure2RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 2:&#039;&#039;&#039; Human erythrocyte catalase. &amp;lt;scene name=&#039;10/1050322/Catalase/1&#039;&amp;gt;Catalase at 20 °C&amp;lt;/scene&amp;gt; (PDB ID [[8wzj]]).&lt;br /&gt;
&lt;br /&gt;
In summary, physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem (Figure 3). These findings lay a platform in achieving optimal freezing conditions for any given macromolecule in the future. &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure3RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 3&#039;&#039;&#039; Physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Crppentamer/3&#039;&amp;gt;CRP Pentamer with CTAB&amp;lt;/scene&amp;gt; (PDB ID [[8wv4]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Crpdecamer/1&#039;&amp;gt;CRP decamer with CTAB&amp;lt;/scene&amp;gt; (PDB ID [[8wv5]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182478</id>
		<title>Journal:Acta Cryst D:S2059798324005229</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182478"/>
		<updated>2024-06-17T14:33:39Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1050322/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===Factors affecting macromolecule orientations in thin films formed in cryo-EM===&lt;br /&gt;
&amp;lt;big&amp;gt;Swati Yadav and Vinothkumar Kutti Ragunath&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2059798324005229&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Single particle cryo-EM has become a routine and indispensable technique in structural biology, where macromolecules are imaged with electrons as single particles and subsequently averaged to obtain a high-resolution 3D reconstruction. Single particle cryo-EM reconstruction utilizes the projection slice theorem to build a 3D map of a 3D object using 2D projections, generated when electrons transmitted through a thin specimen are recorded by a detector. The resolution and quality of the final map depend on many factors including heterogeneity in the specimen, adequate sampling of views and signal-to-noise of the images. &lt;br /&gt;
A key step in this process is to obtain a thin film of macromolecules (purified or as a mixture) in ice and the most routinely used method for obtaining such thin films was developed by Dubochet and his colleagues (Dubochet &#039;&#039;et al.,&#039;&#039; 1988&amp;lt;ref name=&amp;quot;Dubochet1&amp;quot;&amp;gt;PMID:3043536&amp;lt;/ref&amp;gt;). Obtaining the optimal conditions for freezing of a given macromolecule requires testing several parameters. At the moment, it is one of the rate-limiting steps in obtaining high-resolution maps by cryo-EM. During the freezing process, the macromolecules can encounter and interact with the air-water interface, sometimes resulting in a tendency to adapt one or more preferential orientations along with denaturation and dissociation in the case of multi-subunit complexes (D’Imprima &#039;&#039;et al.,&#039;&#039; 2019&amp;lt;ref name=&amp;quot;D’Imprima&amp;quot;&amp;gt;PMID:30932812&amp;lt;/ref&amp;gt;; Noble &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Noble&amp;quot;&amp;gt;PMID: 30250056&amp;lt;/ref&amp;gt;; Glaeser and Han, 2017&amp;lt;ref name=&amp;quot;Glaeser&amp;quot;&amp;gt;PMID: 28781996&amp;lt;/ref&amp;gt;). The 3D maps reconstructed from preferentially oriented macromolecules exhibit stretching of densities in one direction (also called anisotropy, where with enough particles the resolution will be high but the maps are not easily interpretable). One such example is the spike protein shown in Figure 1A, which illustrates the effects of orientation bias on the final reconstruction.&lt;br /&gt;
[[Image:Figure1RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 1:&#039;&#039;&#039; The models used as reference are PDBs [[8h3d]] and [[6cvm]] for the spike protein and b-galactosidase respectively. A) Spike protein, SARS-COV-2. &amp;lt;scene name=&#039;10/1050322/Spike_no_additive/1&#039;&amp;gt;Spike, no additive&amp;lt;/scene&amp;gt; ([[8h3d]]). &amp;lt;scene name=&#039;10/1050322/Spike_with_ctab/1&#039;&amp;gt;Spike with CTAB&amp;lt;/scene&amp;gt; ([[8wzi]]). B) β-galactosidase.&lt;br /&gt;
&lt;br /&gt;
There are multiple ways to address orientation bias including the use of support layers like carbon or graphene, tilting of the stage and more commonly, the use of surfactants or detergents as small molecule additives during grid preparation (Liu and Wang, 2023&amp;lt;ref name=&amp;quot;Liu&amp;quot;&amp;gt;PMID: 36563741&amp;lt;/ref&amp;gt;). There are a number of macromolecules where surfactants have been used to overcome the preferred orientation problem. In this work, we asked if an informed decision regarding the grid freezing conditions can be made based on the properties of the macromolecule. &lt;br /&gt;
We studied macromolecules of different sizes and symmetries (125-440 kDa, C1 to D3) and tested a few commonly used surfactants to overcome the orientation bias and observed that many of these surfactants are beneficial. One such example is cationic surfactant CTAB, which causes changes in the orientation distribution of SARS-CoV-2 spike protein as shown in Figure1A. Further, we tested the effect of poly-histidine tag on orientation distribution of macromolecules. Figure 1B shows the impact of the N-terminal poly-his tag on orientation in the case of the E. coli β-galactosidase enzyme. We assessed the improvement in orientation distribution with different measures including the orientation distribution plot after 3D refinement (Scheres 2012&amp;lt;ref name=&amp;quot;Scheres&amp;quot;&amp;gt;PMID: 23000701&amp;lt;/ref&amp;gt;), Efficiency of orientation distribution (Naydenova &amp;amp; Russo, 2017&amp;lt;ref name=&amp;quot;Naydenova&amp;quot;&amp;gt;PMID: 28931821&amp;lt;/ref&amp;gt;), 3D-FSC (Tan &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Tan&amp;quot;&amp;gt;PMID: 28671674&amp;lt;/ref&amp;gt;) and the map vs model FSC curve. We also tested the effect of grid hole size and temperature during grid preparation on orientation bias demonstrated using human erythrocyte catalase as an example (Figure 2). &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure2RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 2:&#039;&#039;&#039; Human erythrocyte catalase. &amp;lt;scene name=&#039;10/1050322/Catalase/1&#039;&amp;gt;Catalase at 20 °C&amp;lt;/scene&amp;gt; (PDB ID [[8wzj]]).&lt;br /&gt;
&lt;br /&gt;
In summary, physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem (Figure 3). These findings lay a platform in achieving optimal freezing conditions for any given macromolecule in the future. &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure3RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 3&#039;&#039;&#039; Physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Crppentamer/2&#039;&amp;gt;CRP Pentamer with CTAB&amp;lt;/scene&amp;gt; (PDB ID [[8wv4]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Crpdecamer/1&#039;&amp;gt;CRP decamer with CTAB&amp;lt;/scene&amp;gt; (PDB ID [[8wv5]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182477</id>
		<title>Journal:Acta Cryst D:S2059798324005229</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182477"/>
		<updated>2024-06-17T14:22:41Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1050322/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===Factors affecting macromolecule orientations in thin films formed in cryo-EM===&lt;br /&gt;
&amp;lt;big&amp;gt;Swati Yadav and Vinothkumar Kutti Ragunath&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2059798324005229&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Single particle cryo-EM has become a routine and indispensable technique in structural biology, where macromolecules are imaged with electrons as single particles and subsequently averaged to obtain a high-resolution 3D reconstruction. Single particle cryo-EM reconstruction utilizes the projection slice theorem to build a 3D map of a 3D object using 2D projections, generated when electrons transmitted through a thin specimen are recorded by a detector. The resolution and quality of the final map depend on many factors including heterogeneity in the specimen, adequate sampling of views and signal-to-noise of the images. &lt;br /&gt;
A key step in this process is to obtain a thin film of macromolecules (purified or as a mixture) in ice and the most routinely used method for obtaining such thin films was developed by Dubochet and his colleagues (Dubochet &#039;&#039;et al.,&#039;&#039; 1988&amp;lt;ref name=&amp;quot;Dubochet1&amp;quot;&amp;gt;PMID:3043536&amp;lt;/ref&amp;gt;). Obtaining the optimal conditions for freezing of a given macromolecule requires testing several parameters. At the moment, it is one of the rate-limiting steps in obtaining high-resolution maps by cryo-EM. During the freezing process, the macromolecules can encounter and interact with the air-water interface, sometimes resulting in a tendency to adapt one or more preferential orientations along with denaturation and dissociation in the case of multi-subunit complexes (D’Imprima &#039;&#039;et al.,&#039;&#039; 2019&amp;lt;ref name=&amp;quot;D’Imprima&amp;quot;&amp;gt;PMID:30932812&amp;lt;/ref&amp;gt;; Noble &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Noble&amp;quot;&amp;gt;PMID: 30250056&amp;lt;/ref&amp;gt;; Glaeser and Han, 2017&amp;lt;ref name=&amp;quot;Glaeser&amp;quot;&amp;gt;PMID: 28781996&amp;lt;/ref&amp;gt;). The 3D maps reconstructed from preferentially oriented macromolecules exhibit stretching of densities in one direction (also called anisotropy, where with enough particles the resolution will be high but the maps are not easily interpretable). One such example is the spike protein shown in Figure 1A, which illustrates the effects of orientation bias on the final reconstruction.&lt;br /&gt;
[[Image:Figure1RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 1:&#039;&#039;&#039; The models used as reference are PDBs [[8h3d]] and [[6cvm]] for the spike protein and b-galactosidase respectively. A) Spike protein, SARS-COV-2. &amp;lt;scene name=&#039;10/1050322/Spike_no_additive/1&#039;&amp;gt;Spike, no additive&amp;lt;/scene&amp;gt; ([[8h3d]]). &amp;lt;scene name=&#039;10/1050322/Spike_with_ctab/1&#039;&amp;gt;Spike with CTAB&amp;lt;/scene&amp;gt; ([[8wzi]]). B) β-galactosidase.&lt;br /&gt;
&lt;br /&gt;
There are multiple ways to address orientation bias including the use of support layers like carbon or graphene, tilting of the stage and more commonly, the use of surfactants or detergents as small molecule additives during grid preparation (Liu and Wang, 2023&amp;lt;ref name=&amp;quot;Liu&amp;quot;&amp;gt;PMID: 36563741&amp;lt;/ref&amp;gt;). There are a number of macromolecules where surfactants have been used to overcome the preferred orientation problem. In this work, we asked if an informed decision regarding the grid freezing conditions can be made based on the properties of the macromolecule. &lt;br /&gt;
We studied macromolecules of different sizes and symmetries (125-440 kDa, C1 to D3) and tested a few commonly used surfactants to overcome the orientation bias and observed that many of these surfactants are beneficial. One such example is cationic surfactant CTAB, which causes changes in the orientation distribution of SARS-CoV-2 spike protein as shown in Figure1A. Further, we tested the effect of poly-histidine tag on orientation distribution of macromolecules. Figure 1B shows the impact of the N-terminal poly-his tag on orientation in the case of the E. coli β-galactosidase enzyme. We assessed the improvement in orientation distribution with different measures including the orientation distribution plot after 3D refinement (Scheres 2012&amp;lt;ref name=&amp;quot;Scheres&amp;quot;&amp;gt;PMID: 23000701&amp;lt;/ref&amp;gt;), Efficiency of orientation distribution (Naydenova &amp;amp; Russo, 2017&amp;lt;ref name=&amp;quot;Naydenova&amp;quot;&amp;gt;PMID: 28931821&amp;lt;/ref&amp;gt;), 3D-FSC (Tan &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Tan&amp;quot;&amp;gt;PMID: 28671674&amp;lt;/ref&amp;gt;) and the map vs model FSC curve. We also tested the effect of grid hole size and temperature during grid preparation on orientation bias demonstrated using human erythrocyte catalase as an example (Figure 2). &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure2RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 2:&#039;&#039;&#039; Human erythrocyte catalase. &amp;lt;scene name=&#039;10/1050322/Catalase/1&#039;&amp;gt;Catalase at 20 °C&amp;lt;/scene&amp;gt; (PDB ID [[8wzj]]).&lt;br /&gt;
&lt;br /&gt;
In summary, physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem (Figure 3). These findings lay a platform in achieving optimal freezing conditions for any given macromolecule in the future. &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure3RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 3&#039;&#039;&#039; Physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Crpdecamer/1&#039;&amp;gt;CRP decamer with CTAB&amp;lt;/scene&amp;gt; (PDB ID [[8wv5]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182476</id>
		<title>Journal:Acta Cryst D:S2059798324005229</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182476"/>
		<updated>2024-06-17T14:21:13Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1050322/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===Factors affecting macromolecule orientations in thin films formed in cryo-EM===&lt;br /&gt;
&amp;lt;big&amp;gt;Swati Yadav and Vinothkumar Kutti Ragunath&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2059798324005229&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Single particle cryo-EM has become a routine and indispensable technique in structural biology, where macromolecules are imaged with electrons as single particles and subsequently averaged to obtain a high-resolution 3D reconstruction. Single particle cryo-EM reconstruction utilizes the projection slice theorem to build a 3D map of a 3D object using 2D projections, generated when electrons transmitted through a thin specimen are recorded by a detector. The resolution and quality of the final map depend on many factors including heterogeneity in the specimen, adequate sampling of views and signal-to-noise of the images. &lt;br /&gt;
A key step in this process is to obtain a thin film of macromolecules (purified or as a mixture) in ice and the most routinely used method for obtaining such thin films was developed by Dubochet and his colleagues (Dubochet &#039;&#039;et al.,&#039;&#039; 1988&amp;lt;ref name=&amp;quot;Dubochet1&amp;quot;&amp;gt;PMID:3043536&amp;lt;/ref&amp;gt;). Obtaining the optimal conditions for freezing of a given macromolecule requires testing several parameters. At the moment, it is one of the rate-limiting steps in obtaining high-resolution maps by cryo-EM. During the freezing process, the macromolecules can encounter and interact with the air-water interface, sometimes resulting in a tendency to adapt one or more preferential orientations along with denaturation and dissociation in the case of multi-subunit complexes (D’Imprima &#039;&#039;et al.,&#039;&#039; 2019&amp;lt;ref name=&amp;quot;D’Imprima&amp;quot;&amp;gt;PMID:30932812&amp;lt;/ref&amp;gt;; Noble &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Noble&amp;quot;&amp;gt;PMID: 30250056&amp;lt;/ref&amp;gt;; Glaeser and Han, 2017&amp;lt;ref name=&amp;quot;Glaeser&amp;quot;&amp;gt;PMID: 28781996&amp;lt;/ref&amp;gt;). The 3D maps reconstructed from preferentially oriented macromolecules exhibit stretching of densities in one direction (also called anisotropy, where with enough particles the resolution will be high but the maps are not easily interpretable). One such example is the spike protein shown in Figure 1A, which illustrates the effects of orientation bias on the final reconstruction.&lt;br /&gt;
[[Image:Figure1RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 1:&#039;&#039;&#039; The models used as reference are PDBs [[8h3d]] and [[6cvm]] for the spike protein and b-galactosidase respectively. A) Spike protein, SARS-COV-2. &amp;lt;scene name=&#039;10/1050322/Spike_no_additive/1&#039;&amp;gt;Spike, no additive&amp;lt;/scene&amp;gt; ([[8h3d]]). &amp;lt;scene name=&#039;10/1050322/Spike_with_ctab/1&#039;&amp;gt;Spike with CTAB&amp;lt;/scene&amp;gt; ([[8wzi]]). B) β-galactosidase.&lt;br /&gt;
&lt;br /&gt;
There are multiple ways to address orientation bias including the use of support layers like carbon or graphene, tilting of the stage and more commonly, the use of surfactants or detergents as small molecule additives during grid preparation (Liu and Wang, 2023&amp;lt;ref name=&amp;quot;Liu&amp;quot;&amp;gt;PMID: 36563741&amp;lt;/ref&amp;gt;). There are a number of macromolecules where surfactants have been used to overcome the preferred orientation problem. In this work, we asked if an informed decision regarding the grid freezing conditions can be made based on the properties of the macromolecule. &lt;br /&gt;
We studied macromolecules of different sizes and symmetries (125-440 kDa, C1 to D3) and tested a few commonly used surfactants to overcome the orientation bias and observed that many of these surfactants are beneficial. One such example is cationic surfactant CTAB, which causes changes in the orientation distribution of SARS-CoV-2 spike protein as shown in Figure1A. Further, we tested the effect of poly-histidine tag on orientation distribution of macromolecules. Figure 1B shows the impact of the N-terminal poly-his tag on orientation in the case of the E. coli β-galactosidase enzyme. We assessed the improvement in orientation distribution with different measures including the orientation distribution plot after 3D refinement (Scheres 2012&amp;lt;ref name=&amp;quot;Scheres&amp;quot;&amp;gt;PMID: 23000701&amp;lt;/ref&amp;gt;), Efficiency of orientation distribution (Naydenova &amp;amp; Russo, 2017&amp;lt;ref name=&amp;quot;Naydenova&amp;quot;&amp;gt;PMID: 28931821&amp;lt;/ref&amp;gt;), 3D-FSC (Tan &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Tan&amp;quot;&amp;gt;PMID: 28671674&amp;lt;/ref&amp;gt;) and the map vs model FSC curve. We also tested the effect of grid hole size and temperature during grid preparation on orientation bias demonstrated using human erythrocyte catalase as an example (Figure 2). &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure2RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 2:&#039;&#039;&#039; Human erythrocyte catalase. &amp;lt;scene name=&#039;10/1050322/Catalase/1&#039;&amp;gt;Catalase at 20 °C&amp;lt;/scene&amp;gt; (PDB ID [[8wzj]]).&lt;br /&gt;
&lt;br /&gt;
In summary, physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem (Figure 3). These findings lay a platform in achieving optimal freezing conditions for any given macromolecule in the future. &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure3RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 3&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;scene name=&#039;10/1050322/Crpdecamer/1&#039;&amp;gt;CRP decamer with CTAB&amp;lt;/scene&amp;gt; (PDB ID [[8wv5]]).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182475</id>
		<title>Journal:IUCrJ:S2052252524004627</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:IUCrJ:S2052252524004627&amp;diff=4182475"/>
		<updated>2024-06-17T13:14:19Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;underdevelopment&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===From X-ray crystallographic structure to intrinsic thermodynamics of protein–ligand binding using carbonic anhydrase isozymes as a model system===&lt;br /&gt;
&amp;lt;big&amp;gt;Daumantas Matulis&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2052252524004627&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
	<entry>
		<id>https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182449</id>
		<title>Journal:Acta Cryst D:S2059798324005229</title>
		<link rel="alternate" type="text/html" href="https://proteopedia.org/index.php?title=Journal:Acta_Cryst_D:S2059798324005229&amp;diff=4182449"/>
		<updated>2024-06-16T07:15:36Z</updated>

		<summary type="html">&lt;p&gt;Alexander Berchansky: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;StructureSection load=&#039;&#039; size=&#039;450&#039; side=&#039;right&#039; scene=&#039;10/1050322/Cv/1&#039; caption=&#039;&#039;&amp;gt;&lt;br /&gt;
===Factors affecting macromolecule orientations in thin films formed in cryo-EM===&lt;br /&gt;
&amp;lt;big&amp;gt;Swati Yadav and Vinothkumar Kutti Ragunath&amp;lt;/big&amp;gt; &amp;lt;ref&amp;gt;doi: 10.1107/S2059798324005229&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;hr/&amp;gt;&lt;br /&gt;
&amp;lt;b&amp;gt;Molecular Tour&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
Single particle cryo-EM has become a routine and indispensable technique in structural biology, where macromolecules are imaged with electrons as single particles and subsequently averaged to obtain a high-resolution 3D reconstruction. Single particle cryo-EM reconstruction utilizes the projection slice theorem to build a 3D map of a 3D object using 2D projections, generated when electrons transmitted through a thin specimen are recorded by a detector. The resolution and quality of the final map depend on many factors including heterogeneity in the specimen, adequate sampling of views and signal-to-noise of the images. &lt;br /&gt;
A key step in this process is to obtain a thin film of macromolecules (purified or as a mixture) in ice and the most routinely used method for obtaining such thin films was developed by Dubochet and his colleagues (Dubochet &#039;&#039;et al.,&#039;&#039; 1988&amp;lt;ref name=&amp;quot;Dubochet1&amp;quot;&amp;gt;PMID:3043536&amp;lt;/ref&amp;gt;). Obtaining the optimal conditions for freezing of a given macromolecule requires testing several parameters. At the moment, it is one of the rate-limiting steps in obtaining high-resolution maps by cryo-EM. During the freezing process, the macromolecules can encounter and interact with the air-water interface, sometimes resulting in a tendency to adapt one or more preferential orientations along with denaturation and dissociation in the case of multi-subunit complexes (D’Imprima &#039;&#039;et al.,&#039;&#039; 2019&amp;lt;ref name=&amp;quot;D’Imprima&amp;quot;&amp;gt;PMID:30932812&amp;lt;/ref&amp;gt;; Noble &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Noble&amp;quot;&amp;gt;PMID: 30250056&amp;lt;/ref&amp;gt;; Glaeser and Han, 2017&amp;lt;ref name=&amp;quot;Glaeser&amp;quot;&amp;gt;PMID: 28781996&amp;lt;/ref&amp;gt;). The 3D maps reconstructed from preferentially oriented macromolecules exhibit stretching of densities in one direction (also called anisotropy, where with enough particles the resolution will be high but the maps are not easily interpretable). One such example is the spike protein shown in Figure 1A, which illustrates the effects of orientation bias on the final reconstruction.&lt;br /&gt;
[[Image:Figure1RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 1:&#039;&#039;&#039; The models used as reference are PDBs [[8h3d]] and [[6cvm]] for the spike protein and b-galactosidase respectively. A) Spike protein, SARS-COV-2. &amp;lt;scene name=&#039;10/1050322/Spike_no_additive/1&#039;&amp;gt;Spike, no additive&amp;lt;/scene&amp;gt; ([[8h3d]]). &amp;lt;scene name=&#039;10/1050322/Spike_with_ctab/1&#039;&amp;gt;Spike with CTAB&amp;lt;/scene&amp;gt; ([[8wzi]]). B) β-galactosidase.&lt;br /&gt;
&lt;br /&gt;
There are multiple ways to address orientation bias including the use of support layers like carbon or graphene, tilting of the stage and more commonly, the use of surfactants or detergents as small molecule additives during grid preparation (Liu and Wang, 2023&amp;lt;ref name=&amp;quot;Liu&amp;quot;&amp;gt;PMID: 36563741&amp;lt;/ref&amp;gt;). There are a number of macromolecules where surfactants have been used to overcome the preferred orientation problem. In this work, we asked if an informed decision regarding the grid freezing conditions can be made based on the properties of the macromolecule. &lt;br /&gt;
We studied macromolecules of different sizes and symmetries (125-440 kDa, C1 to D3) and tested a few commonly used surfactants to overcome the orientation bias and observed that many of these surfactants are beneficial. One such example is cationic surfactant CTAB, which causes changes in the orientation distribution of SARS-CoV-2 spike protein as shown in Figure1A. Further, we tested the effect of poly-histidine tag on orientation distribution of macromolecules. Figure 1B shows the impact of the N-terminal poly-his tag on orientation in the case of the E. coli β-galactosidase enzyme. We assessed the improvement in orientation distribution with different measures including the orientation distribution plot after 3D refinement (Scheres 2012&amp;lt;ref name=&amp;quot;Scheres&amp;quot;&amp;gt;PMID: 23000701&amp;lt;/ref&amp;gt;), Efficiency of orientation distribution (Naydenova &amp;amp; Russo, 2017&amp;lt;ref name=&amp;quot;Naydenova&amp;quot;&amp;gt;PMID: 28931821&amp;lt;/ref&amp;gt;), 3D-FSC (Tan &#039;&#039;et al.,&#039;&#039; 2018&amp;lt;ref name=&amp;quot;Tan&amp;quot;&amp;gt;PMID: 28671674&amp;lt;/ref&amp;gt;) and the map vs model FSC curve. We also tested the effect of grid hole size and temperature during grid preparation on orientation bias demonstrated using human erythrocyte catalase as an example (Figure 2). &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure2RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 2:&#039;&#039;&#039; Human erythrocyte catalase. &amp;lt;scene name=&#039;10/1050322/Catalase/1&#039;&amp;gt;Catalase at 20 °C&amp;lt;/scene&amp;gt; (PDB ID [[8wzj]]).&lt;br /&gt;
&lt;br /&gt;
In summary, physical and chemical factors affecting macromolecule behaviour on grids have been studied to overcome the preferred orientation problem (Figure 3). These findings lay a platform in achieving optimal freezing conditions for any given macromolecule in the future. &lt;br /&gt;
&lt;br /&gt;
[[Image:Figure3RR5238.png|left|thumb|400px]]&lt;br /&gt;
{{Clear}}&lt;br /&gt;
&#039;&#039;&#039;Figure 3&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;b&amp;gt;References&amp;lt;/b&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&amp;lt;/StructureSection&amp;gt;&lt;br /&gt;
__NOEDITSECTION__&lt;/div&gt;</summary>
		<author><name>Alexander Berchansky</name></author>
	</entry>
</feed>